type (II) diabetes patients. Insulin-dependent diabetes mellitus, Non-insulin-dependent diabetes mellitus, Malnutrition-related diabetes mellitus, Other specified diabetes mellitus, Unspecified diabetes mellitus
Conditions
Interventions
Intervention 1: Test group received oral hypoglycemic agents and Boswellia serrata for 4 weeks (300 mg, three times, chewing and package form) administrated daily. blood samples before and after 4 wee
Treatment - Drugs
Test group received oral hypoglycemic agents and Boswellia serrata for 4 weeks (300 mg, three times, chewing and package form) administrated daily. blood samples before and after 4 weeks of it being d
control group randomized selected from Type 2 diabetic patients during trial,has been treated only with oral hypoglycaemic agents. blood samples before and after 4 weeks of it being done.
Sponsors
Vice Chancellor for Research, Ahvaz Jundishapur University of Medical Sciences.
Eligibility
Sex/Gender
All
Age
30 Years to 65 Years
Inclusion criteria
Inclusion criteria: Including criteria to study: age range between 30-65 years; only use the oral hypoglycemic agents; type 2 diabetic patients Exclusion criteria to study: have Hepatic cirrhosis; pregnant and lactating women; active Proliferative Diabetic Retinopathy (PDR); Chronic Kidney Disease (CKD); Congestive Heart
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood glucose. Timepoint: before and 45 days after intervention. Method of measurement: glucose kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Insulin. Timepoint: before and 45 days after intervention. Method of measurement: insulin kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAkram Ahangarpour
61335189, Department of Physiology, Diabetes Research Center and Physiology Research Center, Ahvaz J
Outcome results
None listed